Consistently, we found PDS treatment significantly reduced many ribosomal proteins, including Rps19 (mutated in 25% of DBA patients), Rps14 (haploinsufficiency in del(5q) MDS patients), and Rpl26 (mutated in certain DBA patients)49. This evidence concerns the gene RPL26 and myelodysplastic syndrome.